GLE Daily Fund Report | Xie Zhiyu increased his position in this stock, A-share turnover remained below 500 billion yuan for the second consecutive day.
82 funds have reduced both management and custody fees within this year.
ETF Midday Review | Traditional Chinese Medicine sector falls, CSI Health Care ETF drops 3.17%.
In the morning, the A-share market experienced volatile adjustments. As of noon, the Shanghai Composite Index fell 0.27%, the Shenzhen Component Index fell 1.17%, and the Chinext Price Index fell 0.96%. The turnover of the two stock markets was 455.8 billion yuan in the morning, an increase of 7.3 billion yuan from the previous trading day. In terms of sectors, the science and technology innovation, semiconductor, weight loss drugs, advanced packaging and other sectors rose the most, while the flying cars, short plays, ST sectors, e-commerce and other sectors fell the most. In terms of ETFs, the chip sector exploded, and the Huaxia Invesco Fund CSI seunion fund chip ETF and the Southern CSI seunion chip ETF both rose 2.91% and 2.90%, respectively. As technology stocks in the US rose, Invesco NASDAQ 100 Technology ETF rose.
Don't panic! Is Xiaomo shouting that they will continue to increase their positions in May?
Is the fund manager's annual salary capped at 1.2 million?
Vaccination demand increased, vaccine bioETFs and biomedical ETFs bucked the trend
On November 30, the vaccine sector bucked the trend. Junshi Biotech and Watson Biotech rose more than 5%, while Bosch Fund Vaccine Biotech ETF, Cathay Fund Vaccine ETF, Cathay Pacific Fund Vaccine ETF, China Merchants Fund Vaccine Leading ETF, Tianhong Fund Biomedical ETF, Wells Fargo Fund Vaccine Index ETF, Penghua Fund Biovaccine ETF, Cathay Pacific Fund Biomedical ETF, and Yifangda Fund Biotechnology ETF rose. The Vaccine Biology ETF tracks the China Securities Vaccine and Biotechnology Index, which selects no more than 50 businesses in the Shanghai and Shenzhen markets involving vaccine research and development, vaccine production, vaccine consumables, and the epidemic
This time the “top class” really ran away!
Pharmaceutical fund manager salty fish turns over
ruthless person! The bearish AI boss fights back against Jedi
Is there a chance for “King of the Year” to turn around?